跳至主要内容
临床试验/NCT03112720
NCT03112720终止3 期

A Comparison of the Efficacy of Sphenopalatine Ganglion (SPG) Block With 5% Lidocaine Versus Epidural Blood Patch (EBP) for the Treatment of Post-Dural Puncture Headache (PDPH)

Rutgers, The State University of New Jersey2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2016年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
8
试验地点
2
主要终点
Number of Headaches With a VAS Score >8/10 Prior to Initiation of Either Therapy

研究概览

简要总结

The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches

详细描述

The sphenopalatine nerve block has been used to treat headaches. Patients have headaches after epidural access from post dural puncture. We need to know if sphenopalatine nerve block will help the patient with the headache.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
13 Years 至 92 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females ages 13-92
  • Subjects have medical diagnosis of PDPH and require treatment
  • Subjects who signed consent/assent

排除标准

  • <13 years of age
  • Pregnancy
  • Subjects with heart failure
  • Subjects already being treated with lidocaine patch or other vehicle for chronic pain
  • Non-english speaking subjects
  • Subjects with platelets <100,000
  • Subjects that are septic
  • Subjects with an allergy to lidocaine
  • Subjects with known nasal polyps
  • Subjects with recent neurological event
  • Subjects on anticoagulant therapy
  • Subjects that received prior therapy with SPG block or EBP

研究组 & 干预措施

Epidural blood patch

Active Comparator

20ml of sterile blood is obtained from the patients arm and placed in the epidural space using standard sterile epidural access.

干预措施: Epidural Blood Patch (Device)

Sphenopalatine Ganglion Block

Experimental

Cotton tip applicators are used to deliver lidocaine to the posterior nares in the area of skin overlying the Sphenopalatine gangion

干预措施: Sphenopalatine Ganglion Block (Drug)

结局指标

主要结局

Number of Headaches With a VAS Score >8/10 Prior to Initiation of Either Therapy

时间窗: Prior to initiation of therapy (Epidural blood patch vs Sphenopalatine Ganglion Block).

Outcome measure will entail recording patient self-reported pain scores to quantify the level of headache pain using the Visual analog scale, meaning 0 - No pain, 1-3 - Mild Pain, 4-6 - Moderate Pain, 7-10 - Severe Pain, by way of in person assessment by pain questionnaire just prior to initiation of either therapy (Epidural blood patch vs Sphenopalatine Ganglion Block).

Number of Participants With a Headache Vas 8/10 at 30 Minutes Following Either Therapy.

时间窗: At 30 minutes following either therapy.

Self-reported pain scores to quantify the level of headache pain using the Visual analog scale (as defined within the description of outcome 1 above) by way of in person assessment by pain questionnaire at 30 minutes following either therapy (Epidural blood patch vs Sphenopalatine Ganglion Block).

Number of Participants With a Headache Vas 8/10 at 60 Minutes Following Either Therapy.

时间窗: At 60 minutes following either therapy.

Self-reported pain scores to quantify the level of headache pain using the Visual analog scale (as defined within the description of outcome 1 above) by way of in person assessment by pain questionnaire at 60 minutes following either therapy (Epidural blood patch vs Sphenopalatine Ganglion Block).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William Grubb, M.D.

Clinical Associate Professor, Anesthesia

Rutgers, The State University of New Jersey

研究点 (2)

Loading locations...

相似试验